Cargando…

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination

BACKGROUND: To optimise the use of available SARS-CoV-2 vaccines, some advocate delaying second vaccination for individuals infected within six months. We studied whether post-vaccination immune response is equally potent in individuals infected over six months prior to vaccination. METHODS: We test...

Descripción completa

Detalles Bibliográficos
Autores principales:	Appelman, Brent, van der Straten, Karlijn, Lavell, A.H. Ayesha, Schinkel, Michiel, Slim, Marleen A., Poniman, Meliawati, Burger, Judith A., Oomen, Melissa, Tejjani, Khadija, Vlaar, Alexander P.J., Wiersinga, W. Joost, Smulders, Yvo M., van Vught, Lonneke A., Sanders, Rogier W., van Gils, Marit J., Bomers, Marije K., Sikkens, Jonne J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461365/ https://www.ncbi.nlm.nih.gov/pubmed/34571363 http://dx.doi.org/10.1016/j.ebiom.2021.103589

Ejemplares similares

Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
por: van Gils, Marit J., et al.
Publicado: (2022)

Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection
por: Lavell, A.H. Ayesha, et al.
Publicado: (2022)

A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern
por: van Gils, Marit J., et al.
Publicado: (2021)

Why not to pick your nose: Association between nose picking and SARS-CoV-2 incidence, a cohort study in hospital health care workers
por: Lavell, A. H. Ayesha, et al.
Publicado: (2023)

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
por: Caniels, Tom G., et al.
Publicado: (2021)

Decreased Passive Immunity to Respiratory Viruses through Human Milk during the COVID-19 Pandemic
por: Grobben, Marloes, et al.
Publicado: (2022)

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
por: Grobben, Marloes, et al.
Publicado: (2021)

Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
por: van der Straten, Karlijn, et al.
Publicado: (2022)

Inflammatory biomarkers at hospital discharge are associated with readmission and death in patients hospitalized for COVID-19
por: Slim, Marleen A., et al.
Publicado: (2021)

Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers
por: Sikkens, Jonne J., et al.
Publicado: (2021)

A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
por: van der Velden, Yme U., et al.
Publicado: (2022)

How Much Overtesting Is Needed to Safely Exclude a Diagnosis? A Different Perspective on Triage Testing Using Bayes' Theorem
por: Sikkens, Jonne J., et al.
Publicado: (2016)

Real-world Evidence of the Effects of Novel Treatments for COVID-19 on Mortality: A Nationwide Comparative Cohort Study of Hospitalized Patients in the First, Second, Third, and Fourth Waves in the Netherlands
por: Slim, Marleen A, et al.
Publicado: (2022)

Using a dog’s superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study
por: Bomers, Marije K, et al.
Publicado: (2012)

Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern
por: van Rijswijck, Danique M. H., et al.
Publicado: (2022)

Personalised immunotherapy in sepsis: a scoping review protocol
por: Slim, Marleen A, et al.
Publicado: (2022)

E-learning on antibiotic prescribing—the role of autonomous motivation in participation: a prospective cohort study
por: Caris, Martine G, et al.
Publicado: (2018)

Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection
por: Guo, Lihui, et al.
Publicado: (2023)

Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual
por: Guerra, Denise, et al.
Publicado: (2023)

Association of clinical sub-phenotypes and clinical deterioration in COVID-19: further cluster analyses
por: Schinkel, Michiel, et al.
Publicado: (2021)

COVID-19 Pathophysiology: An Opportunity to Start Appreciating Time-Dependent Variation
por: van Vught, Lonneke A., et al.
Publicado: (2022)

A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Brinkkemper, Mitch, et al.
Publicado: (2021)

Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study
por: Lankelma, Jacqueline M., et al.
Publicado: (2016)

Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation
por: van der Straten, Karlijn, et al.
Publicado: (2022)

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees
por: Van Coillie, Julie, et al.
Publicado: (2022)

Stay Tuned: What Is Special About Not Shifting Attention?
por: Talsma, Durk, et al.
Publicado: (2011)

ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol
por: Kotsaki, Antigone, et al.
Publicado: (2022)

Comparison of hospital treatment strategy or of treatment actually received in COVID-19?: Commenting on: Lammers AJJ, Brohet RM, Theunissen REP, Koster C, Rood R, Verhagen DWM, et al. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients. Int J Infect Dis. 2020 September
por: Sikkens, Jonne J., et al.
Publicado: (2021)

Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity
por: van Keulen, Britt J., et al.
Publicado: (2021)

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
por: Radić, Laura, et al.
Publicado: (2023)

Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
por: Brinkkemper, Mitch, et al.
Publicado: (2022)

Risk of SARS-CoV-2 transmission upon return to work in RNA-positive healthcare workers
por: Kolodziej, L.M., et al.
Publicado: (2022)

A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
por: Claireaux, Mathieu, et al.
Publicado: (2022)

Artificial Intelligence for Early Sepsis Detection: A Word of Caution
por: Schinkel, Michiel, et al.
Publicado: (2023)

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
por: Schriek, Angela I., et al.
Publicado: (2022)

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
por: Schriek, Angela I., et al.
Publicado: (2022)

Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects
por: Blom, Henk J., et al.
Publicado: (2010)

Conflict of interest disclosure slides at the European Society of Cardiology Congress 2016 in Rome: are they displayed long enough to assess their content? A cross-sectional study
por: van Lieshout, Christianne T, et al.
Publicado: (2018)

Outcomes of persons with coronavirus disease 2019 in hospitals with and without standard treatment with (hydroxy)chloroquine
por: Peters, Edgar JG., et al.
Publicado: (2021)

The homocysteine controversy
por: Smulders, Yvo M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lu9vjcv6vg79pc5do0foko6tdm